33314 Federal Register / Vol. 71, No.
110 / Thursday, June 8, 2006 / Notices
CFR Part 4, Subpart E, shall be deemed
to have waived their rights.
ADDRESSES: A copy of the decision may
be obtained from: Bureau of Land
Management, Alaska State Office, 222
West Seventh Avenue, #13, Anchorage,
Alaska 99513–7599.
FOR FURTHER INFORMATION, CONTACT: The
Bureau of Land Management by phone
at 907–271–5960, or by e-mail at
ak.blm.conveyance@ak.blm.gov. Persons
who use a telecommunication device
(TTD) may call the Federal Information
Relay Service (FIRS) at 1–800–877–
8330, 24 hours a day, seven days a
week, to contact the Bureau of Land
Management.
Eileen M. Ford,
Land Law Examiner, Branch of Adjudication
II.
[FR Doc. E6–8906 Filed 6–7–06; 8:45 am]
BILLING CODE 4310–$$–P
DEPARTMENT OF THE INTERIOR
Bureau of Land Management
[NM–920–1310–06; TXNM 103305]
Proposed Reinstatement of Terminated
Oil and Gas Lease TXNM 103305
AGENCY: Bureau of Land Management,
Interior.
ACTION: Notice of Reinstatement of
Terminated Oil and Gas Lease.
SUMMARY: Pursuant to the provisions of
43 CFR 3108.2–3(b)(2), Texas Land &
Petroleum Company LLC, timely filed a
petition for reinstatement of oil and gas
lease TXNM 103305 for lands in Shelby
County, Texas, and was accompanied by
all required rentals and royalties
accruing from September 1, 2005, the
date of termination.
FOR FURTHER INFORMATION CONTACT:
Gloria S. Baca, BLM, New Mexico State
Office, (505) 438–7566.
SUPPLEMENTARY INFORMATION: No valid
lease has been issued affecting the
lands.
The lessee has agreed to new lease
terms for rentals and royalties at rates of
$10.00 per acre or fraction thereof and
162⁄3 percent, respectively. The lessee
has paid the required $500.00
administrative fee and has reimbursed
the Bureau of Land Management for the
cost of this Federal Register notice. The
lessee has met all the requirements for
reinstatement of the lease as set out in
cprice-sewell on PROD1PC66 with NOTICES
sections 31(d) and (e) of the Mineral
Leasing Act of 1920 (30 U.S.C. 188), and
the Bureau of Land Management is
proposing to reinstate the lease effective
September 1, 2005, subject to the
original terms and conditions of the
VerDate Aug<31>2005 15:37 Jun 07, 2006 Jkt 208001
lease and the increased rental and
royalty rates cited above.
Dated: June 1, 2006.
Gloria S. Baca,
Land Law Examiner, Fluids Adjudication
Team 1.
[FR Doc. E6–8907 Filed 6–7–06; 8:45 am]
BILLING CODE 4310–FB–P
DEPARTMENT OF THE INTERIOR
Bureau of Land Management
[(NM–920–1310–06); (TXNM 107338; TXNM
107329)]
Proposed Reinstatement of Terminated
Oil and Gas Leases TXNM 107338;
TXNM 107329
AGENCY: Bureau of Land Management,
Interior.
ACTION:Notice of Reinstatement of
Terminated Oil and Gas Leases.
SUMMARY: Pursuant to the provisions of
43 CFR 3108.2–3(b)(2), Phillip R Rice,
timely filed a petition for reinstatement
of oil and gas leases TXNM 107338 and
TXNM 107329 for lands in Wise
County, Texas, and was accompanied by
all required rentals and royalties
accruing from December 1, 2005, the
date of termination.
FOR FURTHER INFORMATION CONTACT:
Lourdes B. Ortiz, BLM, New Mexico
State Office, (505) 438–7586.
SUPPLEMENTARY INFORMATION: No valid
lease has been issued that affect the
lands. The lessee has agreed to new
lease terms for rentals and royalties at
rates of $20.00 per acre or fraction
thereof and 182⁄3 percent, respectively.
The lessee has paid the required
$500.00 administrative fee and has
reimbursed the Bureau of Land
Management for the cost of this Federal
Register notice.
The lessee has met all the
requirements for reinstatement of the
lease as set out in sections 31(d) and (e)
of the Mineral Leasing Act of 1920 (30
U.S.C. 188), and the Bureau of Land
Management is proposing to reinstate
the lease effective December 1, 2005,
subject to the original terms and
conditions of the leases and the
increased rental and royalty rate cited
above.
Dated: June 1, 2006.
Lourdes B. Ortiz,
Land Law Examiner, Fluids Adjudication
Team.
[FR Doc. E6–8908 Filed 6–7–06; 8:45 am]
BILLING CODE 4310–FB–P
PO 00000 Frm 00037 Fmt 4703 Sfmt 4703
INTERNATIONAL TRADE
COMMISSION
[USITC SE–06–038]
Government in the Sunshine Act
Meeting Notice
AGENCY HOLDING THE MEETING:
International Trade Commission.
TIME AND DATE: June 19, 2006 at 2 p.m.
PLACE: Room 101, 500 E Street, SW.,
Washington, DC 20436. Telephone:
(202) 205–2000.
STATUS: Open to the public.
MATTERS TO BE CONSIDERED:
1. Agenda for future meetings: None.
2. Minutes.
3. Ratification List.
4. Inv. Nos. 731–TA–1092 and 1093
(Final) (Diamond Sawblades and Parts
Thereof from China and Korea)—
briefing and vote. (The Commission is
currently scheduled to transmit its
determination and Commissioners’
opinions to the Secretary of
Commerce on or before June 30,
2006.)
5. Outstanding action jackets: None.
In accordance with Commission
policy, subject matter listed above, not
disposed of at the scheduled meeting,
may be carried over to the agenda of the
following meeting.
By order of the Commission.
Issued: June 5, 2006.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. 06–5248 Filed 6–6–06; 12:49 pm]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1933—Mobile Enterprise
Alliance, Inc.
Notice is hereby given that, on May
16, 2006, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Mobile Enterprise
Alliance, Inc. has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, PortNexus Corporation,
Miami, FL; and Secgo Software Oy,
Tampere, FINLAND have been added as
E:\FR\FM\08JNN1.SGM 08JNN1
 Federal Register / Vol. 71, No. 110 / Thursday, June 8, 2006 / Notices
parties to this venture. Also, Everypath
Corporation, San Jose, CA; and Adesso
Systems, Boston, MA have withdrawn
as parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and Mobile
Enterprise Alliance, Inc. intends to file
additional written notification
disclosing all changes in membership.
On June 24, 2004, Mobile Enterprise
Alliance, Inc. filed its original
notification pursuant to section 6(a) of
the Act. The Department of Justice
published a notice in the Federal
Register pursuant to section 6(b) of the
Act on July 23, 2004 (69 FR 44062).
The last notification was filed with
the Department on February 22, 2006. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on March 17, 2006 (71 FR 13866).
Dorothy B. Fountain,
Deputy Director of Operations, Antitrust
Division.
[FR Doc. 06–5200 Filed 6–7–06; 8:45 am]
BILLING CODE 4410–11–M
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in Schedule I or II and prior
to issuing a regulation under 21 U.S.C.
952(a)(2)(B) authorizing the importation
of such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on
November 28, 2005, Cambrex Charles
City, Inc., 1205 11th Street, Charles City,
Iowa 50616, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of Phenylacetone (8501), a
basic class of controlled substance listed
in Schedule II.
The company plans to procure
Phenylacetone through importation to
be used as a precursor in the
manufacture of amphetamines only.
cprice-sewell on PROD1PC66 with NOTICES
Any manufacturer who is presently,
or is applying to be, registered with DEA
to manufacture such basic classes of
controlled substances may file
comments or objections to the issuance
of the proposed registration and may, at
VerDate Aug<31>2005 15:37 Jun 07, 2006 Jkt 208001
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than July 10, 2006.
This procedure is to be conducted
simultaneously with and independent
of the procedures described in 21 CFR
1301.34(b), (c), (d), (e) and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substance listed in
Schedule I or II are, and will continue
to be required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a), 21 U.S.C. 823(a), and 21
CFR 301.34(b), (c), (d), (e) and (f) are
satisfied.
Dated: June 1, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–8919 Filed 6–7–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to section 1301.33(a) of Title
21 of the Code of Federal Regulations
(CFR), this is notice that on December
12, 2005, Mallinckrodt Inc., 3600 North
Second Street, St. Louis, Missouri
63147, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in
Schedules I and II:
Drug
Codeine-N-oxide (9053) ...............
Difenoxin (9168) ...........................
Dihydromorphine (9145) ...............
PO 00000 Frm 00038 Fmt 4703 Sfmt 4703
33315
Drug Schedule
Morphine-N-oxide (9307) ............. I
Norlevorphanol (9634) .................. I
Normorphine (9313) ..................... I
Tetrahydrocannabinols (7370) ..... I
Alfentanil (9737) ........................... II
Amphetamine (1100) .................... II
Ecgonine (9180) ........................... II
Codeine (9050) ............................. II
Dextropropoxyphene, bulk (9273) II
Dihydrocodeine (9120) ................. II
Diphenoxylate (9170) ................... II
Diprenorphine (9058) ................... II
Etorphine HCL (9059) .................. II
Fentanyl (9801) ............................ II
Hydrocodone (9193) ..................... II
Hydromorphone (9150) ................ II
Levo-alphacetylmethadol (9648) .. II
Levorphanol (9220) ...................... II
Meperidine (9230) ........................ II
Methadone (9250) ........................ II
Methadone intermediate (9254) ... II
Methamphetamine (1105) ............ II
Methylphenidate (1724) ................ II
Metopon (9260) ............................ II
Morphine (9300) ........................... II
Nabilone (7379) ............................ II
Opium extracts (9610) .................. II
Opium fluid extract (9620) ............ II
Opium tincture (9630) .................. II
Opium, granulated (9640) ............ II
Opium, powdered (9639) ............. II
Oxycodone (9143) ........................ II
Oxymorphone (9652) ................... II
Phenazocine (9715) ..................... II
Remifentanil (9739) ...................... II
Sufentanil (9740) .......................... II
Thebaine (9333) ........................... II
The firm plans to manufacture the
listed controlled substances for internal
use and for sale to other companies.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than August 7, 2006.
Dated: June 1, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Schedule Diversion Control, Drug Enforcement
Administration.
I
I [FR Doc. E6–8917 Filed 6–7–06; 8:45 am]
I BILLING CODE 4410–09–P
E:\FR\FM\08JNN1.SGM 08JNN1